MX2022015495A - Inhibidores de cinasa relacionada con el gen a nunca en mitosis (nek7). - Google Patents

Inhibidores de cinasa relacionada con el gen a nunca en mitosis (nek7).

Info

Publication number
MX2022015495A
MX2022015495A MX2022015495A MX2022015495A MX2022015495A MX 2022015495 A MX2022015495 A MX 2022015495A MX 2022015495 A MX2022015495 A MX 2022015495A MX 2022015495 A MX2022015495 A MX 2022015495A MX 2022015495 A MX2022015495 A MX 2022015495A
Authority
MX
Mexico
Prior art keywords
sup
nek7
inhibitors
compounds
kinase
Prior art date
Application number
MX2022015495A
Other languages
English (en)
Spanish (es)
Inventor
David James Bearss
Alexis Henri Abel Mollard
Iii John Sai Keong Kauwe
Original Assignee
Halia Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Halia Therapeutics Inc filed Critical Halia Therapeutics Inc
Publication of MX2022015495A publication Critical patent/MX2022015495A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
MX2022015495A 2020-06-08 2021-06-08 Inhibidores de cinasa relacionada con el gen a nunca en mitosis (nek7). MX2022015495A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063036244P 2020-06-08 2020-06-08
US202163170776P 2021-04-05 2021-04-05
US202163185257P 2021-05-06 2021-05-06
PCT/US2021/036398 WO2021252488A1 (en) 2020-06-08 2021-06-08 Inhibitors of nek7 kinase

Publications (1)

Publication Number Publication Date
MX2022015495A true MX2022015495A (es) 2023-03-14

Family

ID=76731040

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022015495A MX2022015495A (es) 2020-06-08 2021-06-08 Inhibidores de cinasa relacionada con el gen a nunca en mitosis (nek7).

Country Status (13)

Country Link
US (1) US20230203045A1 (https=)
EP (1) EP4161933A1 (https=)
JP (1) JP2023528659A (https=)
KR (1) KR20230035311A (https=)
CN (1) CN116075513A (https=)
AU (1) AU2021289345A1 (https=)
BR (1) BR112022025012A2 (https=)
CA (1) CA3186041A1 (https=)
CO (1) CO2022019131A2 (https=)
IL (1) IL298849A (https=)
MX (1) MX2022015495A (https=)
TW (1) TWI908811B (https=)
WO (1) WO2021252488A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS65962B1 (sr) 2020-05-08 2024-10-31 Halia Therapeutics Inc Inhibitori nek7 kinaze
US20240400551A1 (en) * 2021-01-25 2024-12-05 Halia Therapeutics, Inc. Nek7 inhibitors
US20240158394A1 (en) * 2022-09-14 2024-05-16 Halia Therapeutics, Inc. Nek7 inhibitors
WO2025140570A1 (zh) * 2023-12-29 2025-07-03 北京普祺医药科技股份有限公司 一种nek7抑制剂、药物组合物及其用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
MXPA03008560A (es) 2001-03-22 2004-06-30 Abbot Gmbh & Co Kg Pirazolopirimidinas como agentes terapeuticos.
US20110189167A1 (en) 2007-04-20 2011-08-04 Flynn Daniel L Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative Diseases
UY33288A (es) 2010-03-25 2011-10-31 Glaxosmithkline Llc Derivados de indolina inhibidores de la proteina quinasa r del reticulo endoplasmatico
EP2802212B1 (en) 2012-01-12 2015-12-30 Basf Se Herbicidal isoxazolo[5,4-b]pyridines
CN105017256A (zh) 2014-04-29 2015-11-04 浙江导明医药科技有限公司 多氟化合物作为布鲁顿酪氨酸激酶抑制剂
RU2724345C2 (ru) 2015-10-09 2020-06-23 Галапагос Нв N-СУЛЬФОНИЛИРОВАННЫЕ ПИРАЗОЛО[3,4-b]ПИРИДИН-6-КАРБОКСАМИДЫ И СПОСОБ ИХ ПРИМЕНЕНИЯ
CN108250200A (zh) 2016-12-28 2018-07-06 中国科学院上海药物研究所 一种具有Axl抑制活性的化合物及其制备和应用
DE102017200543A1 (de) 2017-01-13 2018-07-19 Baden-Württemberg Stiftung Ggmbh Verfahren zur Behandlung einer Oberfläche eines Hartmetallkörpers und zur Beschichtung des behandelten Hartmetallkörpers mit einer Diamantschicht
DE102017118230B4 (de) * 2017-08-10 2021-04-22 Christoph Lucks Verfahren zur Analyse und/oder Überwachung von Brücken sowie entsprechendes System und entsprechende Verwendung
MX2020001776A (es) * 2017-08-15 2020-03-24 Inflazome Ltd Sulfonilureas y sulfoniltioureas como inhibidores de nlrp3.
KR20200087759A (ko) 2017-11-09 2020-07-21 인플라좀 리미티드 신규한 설폰아마이드 카복스아마이드 화합물
IL277408B2 (en) * 2018-04-05 2024-08-01 Merck Patent Gmbh Heteroaryl compounds as IRAK type II inhibitors and their use
AR118119A1 (es) 2019-02-18 2021-09-22 Genentech Inc Compuestos de pirido-pirimidinilo y métodos de uso
CN111646995B (zh) * 2019-03-04 2023-03-21 四川大学 4-氨基-嘧啶并氮杂环-苯基脲类衍生物及其制备方法和用途
WO2021057877A1 (zh) * 2019-09-26 2021-04-01 深圳市塔吉瑞生物医药有限公司 取代的芳香稠合环衍生物及其组合物及用途
AU2020436612A1 (en) * 2020-03-16 2022-09-01 Flash Therapeutics, Llc Compounds for treating or inhibiting recurrence of acute myeloid leukemia

Also Published As

Publication number Publication date
BR112022025012A2 (pt) 2023-02-14
CN116075513A (zh) 2023-05-05
US20230203045A1 (en) 2023-06-29
IL298849A (en) 2023-02-01
CO2022019131A2 (es) 2023-03-07
KR20230035311A (ko) 2023-03-13
WO2021252488A1 (en) 2021-12-16
CA3186041A1 (en) 2021-12-16
JP2023528659A (ja) 2023-07-05
TW202208368A (zh) 2022-03-01
EP4161933A1 (en) 2023-04-12
AU2021289345A1 (en) 2023-01-19
TWI908811B (zh) 2025-12-21

Similar Documents

Publication Publication Date Title
PH12022553024A1 (en) Inhibitors of nek7 kinase
PH12023552774A1 (en) Nek7 inhibitors
MX2022015495A (es) Inhibidores de cinasa relacionada con el gen a nunca en mitosis (nek7).
MX2021000887A (es) Compuestos espiroheterociclicos y metodos de uso de los mismos para el tratamiento de cancer.
MX2021005924A (es) Compuestos y metodos de uso de los mismos para el tratamiento del cancer.
MX2023012361A (es) Inhibidor de parp que contiene estructura de piperazina, metodo de preparacion del mismo y uso farmaceutico del mismo.
WO2018218070A3 (en) COVALENT INHIBITORS OF KRAS
PH12022551226A1 (en) Pyrrolotriazine compounds acting as mnk inhibitor
MX2024000807A (es) Inhibidor de aak1 y uso de este.
WO2016164675A8 (en) Substituted quinazoline compounds and methods of use thereof
MY209754A (en) Amide derivative and preparation method therefore and use thereof in medicine
WO2023205463A8 (en) Heteroaryl compounds for the treatment of pain
MX2024013914A (es) Moduladores del inflamasoma nlrp3 y productos y metodos relacionados
SA522431777B1 (ar) مشتقات ألفا -d- جالاكتو بيرانوسيد
MY206262A (en) Macrocyclic tyrosine kinase inhibitor and uses thereof
MX2023004033A (es) Espiro derivados de alfa-d-galactopiranosidos.
MX418886B (es) Derivado de pirimidina que inhibe el crecimiento de celulas cancerosas y uso medicinal del mismo
EP4599892A3 (en) Boronic acid derivatives and therapeutic uses thereof
ZA202501471B (en) Preparation and use of quinazolinone derivative as kinase inhibitor
MX2023013225A (es) Inhibidores de la cinasa 4 similar a polo.
JOP20240258A1 (ar) مشتقات أوكسو إندولينيل أميد لتثبيط nlrp3 واستخداماتها
MX2023009954A (es) Compuestos de aminopirimidina y métodos de uso de estos.
MX2022016516A (es) Piridina-1,5-dionas que exhiben inhibición de proteínas cinasas activadas por mitogenos que interaccionan con cinasas activadas (mnk) y su método de uso.
CR20200619A (es) Compuestos de cianotriazol y usos de los mismos
WO2024086789A3 (en) Mutant pi3k-alpha inhibitors and their use as pharmaceuticals